1. Home
  2. RNST vs NVAX Comparison

RNST vs NVAX Comparison

Compare RNST & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNST
  • NVAX
  • Stock Information
  • Founded
  • RNST 1904
  • NVAX 1987
  • Country
  • RNST United States
  • NVAX United States
  • Employees
  • RNST N/A
  • NVAX N/A
  • Industry
  • RNST Major Banks
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RNST Finance
  • NVAX Health Care
  • Exchange
  • RNST Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • RNST 3.3B
  • NVAX 1.3B
  • IPO Year
  • RNST N/A
  • NVAX 1995
  • Fundamental
  • Price
  • RNST $38.14
  • NVAX $6.80
  • Analyst Decision
  • RNST Buy
  • NVAX Buy
  • Analyst Count
  • RNST 6
  • NVAX 5
  • Target Price
  • RNST $42.20
  • NVAX $16.60
  • AVG Volume (30 Days)
  • RNST 558.7K
  • NVAX 5.2M
  • Earning Date
  • RNST 07-22-2025
  • NVAX 08-07-2025
  • Dividend Yield
  • RNST 2.31%
  • NVAX N/A
  • EPS Growth
  • RNST 31.26
  • NVAX N/A
  • EPS
  • RNST 3.20
  • NVAX 2.97
  • Revenue
  • RNST $710,265,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • RNST $40.84
  • NVAX $56.85
  • Revenue Next Year
  • RNST $13.45
  • NVAX N/A
  • P/E Ratio
  • RNST $11.90
  • NVAX $2.29
  • Revenue Growth
  • RNST 15.97
  • NVAX 25.92
  • 52 Week Low
  • RNST $26.97
  • NVAX $5.01
  • 52 Week High
  • RNST $39.63
  • NVAX $17.81
  • Technical
  • Relative Strength Index (RSI)
  • RNST 69.71
  • NVAX 51.68
  • Support Level
  • RNST $35.67
  • NVAX $6.23
  • Resistance Level
  • RNST $36.57
  • NVAX $6.90
  • Average True Range (ATR)
  • RNST 0.73
  • NVAX 0.30
  • MACD
  • RNST 0.25
  • NVAX 0.01
  • Stochastic Oscillator
  • RNST 96.66
  • NVAX 67.00

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: